MrBeast's Lunchly Meal Brand Hit By FDA Complaints, Mold Claims
Lunchly, the Lunchables-style brand of snack kits launched by YouTubers Logan Paul, Olajide "KSI" Olatunji, and Jimmy ...
The Express Tribune15d
FDA reviewing complaints about Lunchly product following mold concerns
The pre-packaged meal product backed by internet stars Logan Paul, KSI, and MrBeast. Following reports of moldy ingredients, ...
JD Supra8d
Navigating Government Investigations: A Guide for FDA-Regulated Companies
Government investigations are an ever-present reality for companies operating in FDA-regulated industries. Whether you're in ...
globalcosmeticsnews5d
FDA Issues Final Guidance to Tattoo Industry on Preventing Ink Contamination Risks
The FDA has issued final guidance aimed at tattoo ink manufacturers, distributors, and packers on preventing microbial ...
Andhra Sugars aspirin unit passes US FDA check
the US FDA has determined that the inspection has been classified as ‘No Action Indicated’ (NAI) without any Form 483 ...
FDA Regulatory Compliance for Drug and Biotech Product Training Course (ONLINE EVENT: December 2-3, 2024/ON-DEMAND)
The "FDA Regulatory Compliance for Drug and Biotech Product Training Course" training has been added to ResearchAndMarkets.com's offering. This course will benefit professionals involved in working ...
foxbangor15d
FDA Receiving Complaints Over Logan Paul, KSI, MrBeast's Lunchly Meals
Logan Paul, KSI and MrBeast's moldy Lunchly fiasco is on the FDA's radar ... with the agency telling TMZ Sports it has received numerous complaints surrounding the internet superstars' most ...
ndtvprofit10d
Biocon Biologics' Bengaluru Facility Receives Voluntary Action Classification From FDA
Biocon Biologics on Wednesday said its drug substance facility in Bengaluru has been classified as voluntary action indicated ...
The Hindu1d
Granules unit in Andhra Pradesh gets U.S. FDA inspection report with NAI status
Drugmaker Granules India has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration ... From April 8-12, the U.S. FDA had conducted a comprehensive pre-approval ...
Pharmabiz10d
Biocon Biologics' Bengaluru unit classified as voluntary action indicated by US FDA
Biocon Biologics' Bengaluru unit classified as voluntary action indicated by US FDA: Our Bureau, Bengaluru Thursday, October 31, 2024, 12:15 Hrs [IST] Biocon Biologics said its dr ...
Pharmabiz4d
Venus Remedies’ Baddi robotic pre-filled syringe facility receives Malaysian PIC/S GMP approval
adding to the GMPs already secured by the company from more than 25 regulatory authorities, including the WHO, European Union and Saudi Arabia. The company has more than 35 marketing authorisations ...